I We used ASL to understand the midazolam-induced episodic memory impairments. I A double-blind, within-subject cross-over design was used. I Left DLPFC showed decreased CBF under midazolam. I Midazolam-induced neural changes in left DLPFC were significantly correlated with memory performance. I These findings provide converging evidence that left DLPFC plays a critical role in new associations' formation. a r t i c l e i n f o 
Introduction
Benzodiazepines are GABA (gamma aminobutyric acid) agonists that have been used safely in research on memory [8, 12] . GABA is the primary inhibitory neurotransmitter in the mammalian central nervous system and the GABA A receptors are expressed in cerebral cortex, hippocampus, basal ganglia, thalamus, cerebellum, and brainstem [31] . Midazolam, like benzodiazepines in general, promotes transient anterograde amnesia [2, 6, 11, 15] and as such, provides a promising tool for studying human memory that finesses problems inherent in patient populations. Some of our previous work has suggested that midazolam-induced memory effects occur by inhibiting the formation of new associations [14, 17, 18] . Less clear, however, are the neural underpinnings of this effect. For example, previous research has highlighted the role of the hippocampus in relational binding and its critical role in explaining anterograde amnesia [4, 7, 22] . It is also known that the hippocampus is one of the regions affected by benzodiazepines due to the high density of GABA A receptors in this region. Consequently, there is a reason to believe that midazolam impairs formation of associations because it impairs hippocampal functioning. The goal of this paper is to combine the use of arterial spin labeling (ASL) perfusion 0304 MRI with midazolam in order to examine the neural mechanisms of memory and possible causes of anterograde amnesia.
Why use ASL with midazolam?
Neuroimaging studies that use fMRI and measure the blood oxygenation level dependent (BOLD) signal may not be optimal when sedatives such as benzodiazepines are involved. Oxygen is extracted from blood in the capillaries, and the resulting deoxyhemoglobin travels into the venous circulation. Because of this, the BOLD signal may be localized to veins that may be as far as a few centimeters from the site of neuronal activity.
In contrast to BOLD fMRI, ASL directly measures cerebral blood flow (CBF) by using arterial blood water as an endogenous contrast agent [10] . The ASL signal is mainly localized to arteries, capillaries, and brain tissue, and its localization is believed to be closer in space to the true sites of neuronal activity than the BOLD signal [9] .
Other advantages of ASL over BOLD fMRI include the lower inter-subject and inter-session variation and minimal sensitivity to magnetic-field inhomogeneity effects [26, 27] . The administration of a drug often increases the inter-subject variability due to the differences in the rate a given drug is metabolized by subjects. The sum of drug-related inter-subject variability and scanning-related variability (that characterizes the BOLD fMRI) might hinder a true signal. This makes ASL especially useful for neuroimaging of psychopharmacological effects.
Review of possible regions influenced by midazolam
Studies involving benzodiazepines that have focused on the regional specificity of drug-induced memory impairment effects found a significantly diminished repetition-related attenuation effect in extrastriate, prefrontal [24] and occipito-temporal [23] regions. Such studies have also found a decrease in the extent and magnitude of activation within the hippocampal, fusiform, and inferior prefrontal cortices during encoding of face-name associations [21] . Furthermore Mintzer et al. [12] found a doserelated deactivation in encoding-associated areas, such as right prefrontal cortex, left parahippocampal gyrus and left anterior cingulate cortex. However, no previous study used ASL to examine the effect of midazolam nor related changes in memory performance with changes in activation induced by the injection of the drug.
Relating memory performance to CBF changes under the influence of midazolam
In this experiment, a long list of word-pairs was divided into four short lists, such that one-fourth of the word pairs were studied prior to injection, another quarter immediately after injection, another quarter of the pairs mid-way through an unrelated task and the final quarter of the word-pairs at the completion of the unrelated task. Performance should be very poor for word pairs studied immediately after injection in the midazolam condition but performance should slowly improve over time for the next two lists (see [17] for more details). An obvious prediction is that performance will be much better for the words shown before injection, regardless of drug condition. In order to understand the relationship between the drug-induced changes in CBF and memory performance, we plan to correlate subjects' neural activity with accuracy on the cued-recall test separately for the two different drug/saline sessions.
Method

Subjects
Nine (4 female) healthy paid volunteers (18-35 years old) participated in the study. All were screened by a medical doctor and gave their written informed consent for a protocol approved by the Institutional Review Boards (IRBs) of Carnegie Mellon University and the University of Pittsburgh. They received $150 compensation for their participation over two sessions.
Design and materials
In a within-subject, double-blind, cross-over design, subjects received midazolam in one session and saline in the other, with the two sessions occurring approximately one week apart. Stimuli consisted of 192 different English concrete nouns that were randomly paired to make 96 unique word pairs (e.g., table-cat) for the two study sessions, half used at each session. The 48 word pairs were divided into 4 sub-lists of 12 word pairs each.
Procedure
Prior to entering the scanner, subjects were instructed as to the nature of the paired associate learning task and subsequent cuedrecall test. They were told that they would passively view word pairs and should try to remember them for a later memory test outside the scanner. Word-pairs were presented individually for 15 s each while subjects lay still in the scanner. While viewing the word pairs, subject's brain activity was imaged using ASL. Each short list was presented over a period of 3 min.
The first study list was shown immediately after structural images were taken and immediately before the injection of the drug or saline. The second list of 12 pairs was shown immediately after injection. Each word pair was shown on the screen for 15 s such that each study block lasted 3 min.
Following the presentation of the second of the four lists, subjects began a different task (a visual search task, using BOLD) that will not be reported here. After completing half of the visual search task, subjects studied the third list of 12 word pairs (again using ASL). The final 12 word pairs were studied after all trials of the other task were completed. The time in the scanner was approximately 1 h, including 10 min for structural data.
Each session was followed by several tests outside the scanner including the cued recall test. Subjects were given a sheet of paper with the 48 stimulus (left-hand) words on a different line of the page. Subjects were asked to write down the corresponding response (right-hand) word of the pair if it could be recalled. The presentation order of the word pairs was a different random order than the study order of the word pairs in the scanner.
Drug administration
After the first ASL block that involved viewing the first list of 12 word pairs and while still lying in the bore, the subject was given a single bolus injection, within a 2-min period, of either midazolam (0.03 mg/kg of the subject's body mass) or a matching volume of saline.
Imaging-data acquisition
MRI data were collected on a 3 T Siemens Tim Trio MRI scanner equipped with a standard transmit/receive head coil. A pulsed arterial spin labeling (PASL) sequence was used for perfusion fMRI scans. Interleaved images with and without labeling were acquired using a gradient echo planar imaging sequence (TR/TE/TI = 3000/20/1800 ms; flip angle = 90 • ). The tagging/control duration was 0.7 s. 19 oblique slices (thickness/gap = 5/1 mm, field of view = 224 mm × 224 mm, matrix = 70 × 70, voxel = 3.2 mm × 3.2 mm × 5 mm) covered the whole brain. For registration purposes, high-resolution anatomical images were acquired using a 3D magnetization prepared rapid gradient echo (MPRAGE) T1-weighted sequence (TR = 2100 ms, TE = 3.63 ms, inversion time (TI) = 1100 ms, flip angle = 8 • , 192 contiguous slices of 1.0 mm thickness; the images were reconstructed as a 192 × 416 × 512 matrix with a 1.0 mm × 0.5 mm × 0.5 mm spatial resolution) for each subject. The total length of scan time lasted ∼1 h including the perfusion scan (each block with 60 acquisitions lasted 3 min), anatomic scan, and other scans for BOLD imaging.
Data analysis
Perfusion fMRI data were analyzed offline using the ASL Data Processing Toolbox [29] and the SPM5 software package. Data analysis focused on trials immediately before and immediately after intravenous midazolam injection so that the effect due to the drug was maximal (i.e., had not yet started to wear off, Schwagmeier et al. [20] ).
The steps of ASL data analysis were similar to those in Wang et al. [28] . MR image series were first realigned to correct for head movements, co-registered with each subject's structural MRI, and spatially smoothed with a 12-mm full-width at half-maximum (FWHM) Gaussian kernel. Subjects' head motion was less than 1.5 mm in any of the x, y, or z directions and less than 1.5 • of any angular motion throughout the course of scan. Perfusionweighted images series were generated by pair-wise subtraction of the label and control images, followed by conversion to absolute CBF image series based on a single compartment continuous arterial spin labeling perfusion model [28] . Individual mean CBF images for each block were normalized into a canonical space (Montreal Neurological Institute standard brain) with re-sampling to 3 mm × 3 mm × 3 mm. A paired t-test was performed using SPM5 to examine the effect of the MZ injection (before the MZ injection vs. after MZ injection (pre MZ vs. post MZ)) and the effect of the saline injection ((before the saline injection vs. after saline injection (pre SA vs. post SA)) under a combined threshold of p < 0.005 and cluster size ≥ 675 mm 3 . This yields a corrected threshold of p < 0.05, determined by Monte Carlo simulation using the AlphaSim program (FWHM = 12 mm, with a mask of the whole brain gray matter tissues). Then, the two contrasts were compared using a random-effect two-sample t-test in the voxels activated in the pre MZ vs. post MZ or pre SA vs. post SA contrasts. The resulting images were thresholded at a combined threshold of p < 0.01 and cluster size ≥ 135 mm 3 , which yields a corrected threshold of p < 0.001, determined by the AlphaSim program (FWHM = 12 mm and the contrasts of pre MZ vs. post MZ or pre SA vs. post SA as masks). Based on the activation clusters from the above contrasts, we defined functional regions of interest (ROIs) using the WFU PickAtlas toolbox. The CBF changes extracted from each subject's data from these ROIs were used for the Pearson's correlation analysis of the drug-induced changes in neural and behavioral performance.
Results
Due to technical failures, data from two subjects were incomplete and could not be analyzed, leaving seven complete data sets (two sessions per subject) for the analysis.
Behavioral data
A 2 × 2 within subjects repeated measures ANOVA was performed on the cued-recall data (Fig. S1 ). There was a main effect of drug session, F(1,6) = 7.1, p < 0.01, whether studied pre-or postinjection, F(1,6) = 5.2, p < 0.1, and an interaction between these two factors F(1,6) = 15.1, p < 0.01. A planned comparison of pre-vs. post-injection conditions revealed a significant difference under midazolam F(1,6) = 16.4, p < 0.01, but not under saline F(1,6) = 0.3, p > 0.1.
Imaging data
We first compared CBF pre-vs. post-injection in the midazolam condition. This analysis revealed decreases in the left middle frontal gyrus (BA 46), right superior and middle frontal gyrus (BA 9, 10), left inferior temporal gyrus (BA 20) , left cingulate gyrus (BA 24), left PCu (BA 31, 7), right precentral gyrus (BA 4), right thalamus and right caudate (Table S1 and Fig. S2 ). There was also an effect on CBF of pre-vs. post-injection in the saline condition: The contrasts were reliable in the left inferior temporal gyrus/fusiform gyrus (BA 37), left caudate/insula (BA 13), right putamen/caudate/inferior frontal gyrus (BA 47) and right superior temporal gyrus (BA 13/41/42) (Table S2 and Fig. S3 ).
Given our interest in the effects of midazolam on brain activity as opposed to the effects of injection per se (e.g., emotion experience due to the injection), we contrasted the effect of midazolam injection with the effect of the saline injection. The results of this contrast are shown in Table 1 (Fig. S4) . Even after controlling for the effect of injection, midazolam-induced decreases still remain in the left middle frontal gyrus (BA 46) (Fig. 1) , left cingulate gyrus (BA 24) and left posterior cingulate/precuneus (PCC/PCu, BA 31, 7).
Correlation between behavioral and imaging data
Three functional ROIs that survived the correction for the effect of injection (Table 1) were defined based on the corresponding clusters in Table S1 . We then correlated the changes in CBF from pre-to post-injection in these three ROIs with the difference in cued recall accuracy for word-pairs studied pre-vs. post-injection. In the midazolam condition there was a remarkably strong correlation in the left middle frontal gyrus (r = 0.80, p < 0.05), but not in the saline condition (r = 0.002) (Fig. S5) . The correlations for the other two ROIs were not reliable for either drug condition (MZ: left cingulate gyrus, r = 0.07; left PCC/PCu, r = −0.34; SA: left cingulate gyrus, r = −0.21; left PCC/PCu, r = 0.55).
The effect of midazolam on memory performance immediately after injection was huge (no subject recalled any words studied in that block). That means that the correlations in the midazolam condition were driven by changes from the baseline in the pre-injection condition. To examine whether the strong correlation was somehow caused by the floor effect for items studied immediately after the midazolam injection, we also correlated CBF changes between the first (pre-injection) and fourth (final) encoding blocks, using the difference in memory performance between first and fourth list. The final block memory performance was not at the floor 1 because the drug had begun to wear off (approximately 40 min after injection) and the delay from study to test was shortest (the posttest recall accuracy for word-pairs is plotted as a function of all four study blocks and drug condition in Fig. S6 ). The correlation in the left DLPFC was strong, r = 0.63, but only marginally significant (one-tailed test). The correlation of CBF and memory performance in the left cingulate gyrus was moderate but not significant, r = −0.39, while in the left PCC/PCu it was strong, r = −0.73, and reached significance at p < 0.05, one-tailed.
Discussion
In this study, healthy subjects were scanned, using ASL, while encoding word pairs under midazolam in one session and under saline in another. Of interest was the effect of the drug manipulation on CBF during encoding of pair associates. As expected, the injection of midazolam severely impaired subjects' memory for word pairs. Consistent with previous BOLD fMRI and PET studies, the analysis of the ASL data revealed midazolam-induced CBF decreases in frontal, temporal, parietal and some subcortical regions [21, 29, 20, 28, 25] . Unlike previous studies, this experiment used a within-subject, double-blind design. This allowed us to compare changes pre-vs. post-injection under saline for any effects due to anticipation of a drug or fear from an injection. Noteworthy, the left DLPFC, the left cingulate gyrus and the left PCC/PCu were activated even after we controlled for these effects.
We also investigated whether the neural decreases in the ROIs listed above (by subject) were correlated with a given subject's difference in memory performance pre-vs. post-injection of midazolam. We did not find a reliable correlation between memory performance and neural effects in either the left cingulate gyrus or the left PCC/PCu, suggesting that these regions may contribute more to the drug's sedative effect than to memory impairment. However, a significant positive correlation between the drop in memory performance and the decrease in the CBF was found in the left DLPFC. Previous non-drug studies also have implicated left DLPFC in encoding of associations between items [13, 1] , providing converging evidence for this interpretation. This finding also provides further support for our view that midazolam blocks the formation of long-term memory associations [14, 17] .
One alternative explanation for the effect of midazolam on memory is that the memory failures reflect an impairment of consolidation of newly formed associations in long-term memory rather than their formation per se (c.f., [16, 3] ). This interpretation seems unlikely because retrieval of associations formed just prior to the midazolam injection were unaffected by the drug.
Some previous studies have found that left DLPFC is a part of the attention network [5] . This suggests that decreases in DLPFC under midazolam may adversely affect attention to a stimulus during encoding rather than blocking the formation of new bindings/associations. Although we did not measure sedation using related tests such as Visual Analogue Scales (VAS) [30] , we have a reason to believe that memory impairment should not be attributed to a lack of attention. First, subjects' performance in other tasks involving midazolam [14] showed no evidence of impairment in attention (e.g., speed and accuracy in a visual search task). Second, subjects received a very low-dose of midazolam (i.e., 0.03 mg/kg of the subject's body mass). Third, the anesthesiologists and experimenters typically could not identify whether the subjects' drug condition was midazolam or saline.
The hippocampus is considered to be critical to associative memory [4, 7, 22] . However, contrary to these expectations, we failed to observe decreases in hippocampal activation under midazolam. The failure to detect changes in hippocampal activity is sometimes reported in the neuroimaging literature. For example, Veselis et al. [25] failed to detect hippocampal deactivation under midazolam; however, in a later study they found a dose-dependent hippocampal effect [19] . One reason for a lack of a hippocampal effect is a low signal to noise ratio due to the shape and location of hippocampus [32] . Another reason for the failure to observe a decreased CBF in hippocampus in our study may be related to the relatively large voxel size (5 × 5 × 3) we used. To isolate the small hippocampal region, it may be necessary to use smaller voxels.
To our knowledge, a combined psychopharmacological and ASL methodology has not been previously implemented to inves- Fig. 1. (A) Midazolam-induced decrease in activation in left DLPFC ROI defined from clusters shown in Table S1 ; (B) a plot of the decreased CBF changes after injection in the left DLPFC in the midazolam and saline conditions. tigate the neural mechanisms of memory. In this double-blind, within-subject design experiment, we used ASL to understand the midazolam-induced episodic memory impairments. Our results suggest that midazolam disrupts activation in left DLPFC, thus impairing the formation of new associations. In addition, we also identified novel patterns of neural activity due to enhanced spatial localization and lower variability between and within imaging sessions.
